6 unchanged sentences
We intend to retain future earnings, if any, to finance the operation and expansion of our business and do not anticipate paying any cash dividends in the foreseeable future.
−Removed: Payment of future cash dividends, if any, will be at the discretion of our board of
−Removed: directors after taking into account various factors, including our financial condition, operating results, current and anticipated cash needs, the requirements and contractual restrictions of then-existing debt instruments, and other factors that our board of directors deems relevant.
+Added: Payment of future cash dividends, if any, will be at the discretion of our board of directors after taking into account various factors, including our financial condition, operating results, current and anticipated cash needs, the requirements and contractual restrictions of then-existing debt instruments, and other factors that our board of directors deems relevant.
+Added: Stock Performance Graph
+Added: This graph is not “soliciting material” or deemed “filed” with the Securities and Exchange Commission (SEC) for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liabilities under that Section, and shall not be deemed incorporated by reference into any filing of Edgewise Therapeutics, Inc.
+Added: under the Securities Act of 1933, as amended, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.
+Added: The following graph compares the cumulative total stockholder return on our common stock relative to the cumulative total returns of the Nasdaq Composite Index and the Nasdaq Biotechnology Index.
+Added: An investment of $100 is assumed to have been made in our common stock and each index on March 26, 2021 (the first day of trading of our common stock) and its relative performance is tracked through December 31, 2025.
+Added: Pursuant to applicable SEC rules, all values assume reinvestment of the full amount of all dividends, however no dividends have been declared on our common stock to date.
+Added: The stockholder returns shown on the graph below are based on historical results and are not necessarily indicative of future performance, and we do not make or endorse any predictions as to future stockholder returns.
Holders of Record
3 unchanged sentences
Recent Repurchases of Equity Securities
−Removed: Use of Proceeds from Public Offering of Common Stock
−Removed: On March 25, 2021, our registration statement on Form S-1 (File No.
−Removed: 333- 253923) and Form S-1MEF (File No.
−Removed: 333- 254739) was declared effective by the SEC for our initial public offering of common stock.
−Removed: We began trading on the Nasdaq Global Select Market on March 26, 2021 and the IPO formally closed on March 30, 2021.
−Removed: In connection with our IPO, we issued and sold an aggregate of 12,650,000 shares of our common stock at a price of $16.00 per share, including 1,650,000 shares of our common stock issued and sold in connection with the full exercise by the underwriters of their option to purchase additional shares of common stock.
−Removed: The gross proceeds from the offering for shares sold in our IPO was $202.4 million.
−Removed: The joint book-running managers for the initial public offering were J.P.
−Removed: Morgan Securities LLC, Goldman Sachs & Co.
−Removed: LLC and SVB Leerink LLC.
−Removed: After deducting underwriting discounts and commissions and offering costs paid or payable by us of approximately $16.3 million, the net proceeds from the offering were approximately $186.1 million.
−Removed: No payments were made by us to directors, officers or persons owning ten percent or more of our common stock or to their associates, or to our affiliates, other than payments in the ordinary course of business to officers for salaries and to non-employee directors pursuant to our director compensation policy.
−Removed: There has been no material change in the planned use of proceeds from our IPO as described in our final prospectus filed with the SEC on March 26, 2021 pursuant to Rule 424(b)(4).
−Removed: We invested the funds received in interest-bearing investment-grade securities.
Use of Proceeds from Follow-On Offering
3 unchanged sentences
After deducting underwriting discounts and commissions of $8.3 million and offering costs of $0.5 million, the net proceeds from the follow-on offering were approximately $129.2 million.
−Removed: There has been no material change in the planned use of proceeds in our follow-on offering as described in our final prospectus filed with the SEC on September 14, 2022 pursuant to Rule 424(b)(5).
+Added: There has been no material change in the planned use of proceeds from our follow-on offering as described in our final prospectus filed with the SEC on September 14, 2022 pursuant to Rule 424(b)(5).
We invested the funds received in interest-bearing investment-grade securities.
7 unchanged sentences
We invested the funds received in interest-bearing investment-grade securities.
−Removed: Use of Proceeds from Underwritten Registered Direct Offering
+Added: Use of Proceeds from the 2024 Underwritten Registered Direct Offering
On January 23, 2024, we closed an underwritten registered direct offering pursuant to a shelf registration statement on Form S-3 (File No.
333-264083) with the SEC that became effective on May 5, 2022 and Form S-3 MEF (File No.
−Removed: 333-276595) that became effective on January 19, 2024, of 21,818,182 shares of common stock at a public offering price of $11.00 per share.
−Removed: The aggregate gross proceeds from the underwritten registered direct offering were $240.0 million, and the net proceeds were $231.9 million after deducting underwriting discounts and commissions of $7.5 million and offering expenses of $0.6 million.
−Removed: There has been no material change in the planned use of proceeds in our January 2024 Offering as described in our final prospectus filed with the SEC on January 19, 2024 pursuant to Rule 424(b)(5).
+Added: 333-276595) that became effective on January 19, 2024, of 21,818,182 shares of common stock at a public offering price of $11.00 per share (January 2024 Offering).
+Added: The aggregate gross proceeds from the January 2024 Offering were $240.0 million, and the net proceeds were $231.9 million after deducting underwriting discounts and commissions of $7.5 million and offering expenses of $0.6 million.
+Added: There has been no material change in the planned use of proceeds from our January 2024 Offering as described in our final prospectus filed with the SEC on January 19, 2024 pursuant to Rule 424(b)(5).
We invested the funds received in interest-bearing investment-grade securities.
+Added: Use of Proceeds from the 2025 Underwritten Registered Direct Offering
+Added: On April 3, 2025, we closed an underwritten registered direct offering pursuant to an automatic shelf registration statement on Form S-3ASR (File No.
+Added: 333-279299) with the SEC that became effective on May 10, 2024, of 9,935,419 shares of common stock at a public offering price of $20.13 per share (April 2025 Offering).
+Added: The aggregate gross proceeds from the April 2025 Offering were $200.0 million, and the net proceeds were $187.1 million, after deducting underwriting discounts and commissions of $12.0 million and offering expenses of $0.9 million.
+Added: There has been no material change in the planned use of proceeds from our April 2025 Offering as described in our final prospectus filed with the SEC on April 2, 2025 pursuant to Rule 424(b)(5).
+Added: We invested the funds received in interest-bearing investment-grade securities.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.